SureTrader
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

NNVC RSS Feed
Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: Ex Actuary, NewMoney, drkazmd65
Search This Board: 
Last Post: 2/25/2018 4:15:56 AM - Followers: 464 - Board type: Free - Posts Today: 3

NanoViricides, Inc (NNVC)

 
 
http://www.nanoviricides.com/index.html
 

 
Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
Email:  info@nanoviricides.com
 
CIK:  0001379006
 
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
 
 
Management:  http://www.nanoviricides.com/board.html
 
Pipeline:   http://www.nanoviricides.com/pipeline.html
 
Recent News:  http://finance.yahoo.com/q/h?s=NNVC



 
Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:
 

 
 
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001379006&owner=exclude&count=40
 
Share Structure:  See SEC filings for current share structure
 
Investor Relations:
Amanda Schuon, 310-550-7200
info@nanoviricides.com



 
 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
 
SureTrader
NNVC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
NNVC News: NanoViricides Files Quarterly Report for Period Ending December 31, 2017 02/21/2018 07:00:00 AM
NNVC News: Quarterly Report (10-q) 02/20/2018 01:55:19 PM
NNVC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 02/14/2018 05:57:04 PM
NNVC News: Current Report Filing (8-k) 12/15/2017 10:29:10 AM
NNVC News: Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates 12/06/2017 07:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#136527  Sticky Note NEWS -- Nanoviricides Initiates a Safety/Toxicology Study of Paulness 12/06/17 08:02:43 AM
#135246  Sticky Note " The Company does not currently have a arvitar 10/06/17 08:49:18 PM
#138045   So far everything looks likely to go as JG36 02/25/18 04:15:56 AM
#138044   What they have told the public in their JG36 02/25/18 04:08:27 AM
#138043   Gene, thanks for nothing. Had he said JG36 02/25/18 04:04:01 AM
#138042   Aren’t you the one who claimed he started Nanotoday 02/24/18 09:35:22 PM
#138041   Yes, by transferring their money to Diwan through Theracour. arvitar 02/24/18 08:16:43 PM
#138040   It's likely that with flucide, they could not mdphd1 02/24/18 07:57:44 PM
#138039   "Gene put the shareholders first." loanranger 02/24/18 07:28:51 PM
#138038   I FOR ONE APPRECIATE GENE'S PAST EFFORTS AND Trendliner 02/24/18 05:22:29 PM
#138037   Is it possible they had the meetings with Nanotoday 02/24/18 02:40:07 PM
#138036   Now how could I know that? Please Nanotoday 02/24/18 02:32:12 PM
#138035   Thanks for the informative commentary about having some KMBJN 02/24/18 01:07:01 PM
#138034   Diwan was reported to have said at the arvitar 02/24/18 11:25:00 AM
#138033   It sure would be nice to hear arvitar 02/24/18 10:53:31 AM
#138032   Very astute. Ubertino 02/24/18 10:41:27 AM
#138031   Please describe the alleged physical limitation of nanoviricide KMBJN 02/24/18 06:16:36 AM
#138030   The reason why everyone in the company knows Nanotoday 02/24/18 12:45:43 AM
#138029   If there are some here who know what KMBJN 02/23/18 11:18:47 PM
#138028   Of course I read it. If Nanotoday 02/23/18 11:12:11 PM
#138027   Can’t seem to get out of penny land NewMoney 02/23/18 10:05:03 PM
#138026   No, it doesn't sound like you read what KMBJN 02/23/18 09:09:41 PM
#138024   From the 10Q, page 23: Nanotoday 02/23/18 08:39:22 PM
#138023   I don't understand. arvitar 02/23/18 08:16:24 PM
#138022   I'd imagine a characterization of particle size, KMBJN 02/23/18 04:33:33 PM
#138021   Actually I'm sure Dr. Seymour was trying to JG36 02/23/18 04:18:02 PM
#138020   Some questions need long answers. The parts of loanranger 02/23/18 12:15:05 PM
#138019   In re IP licensing/compensation: Ubertino 02/23/18 11:45:41 AM
#138018   Nano Vision Ubertino 02/23/18 10:58:15 AM
#138017   Are you saying that there is some less-than-100% arvitar 02/23/18 10:51:04 AM
#138015   Quiz: Who is behind this CEO search? Ubertino 02/23/18 10:05:52 AM
#138014   After all this time, do you really expect noretreat 02/23/18 09:52:29 AM
#138013   "Say it isn’t so." loanranger 02/23/18 08:35:28 AM
#138012   I guess I didn't get it. loanranger 02/23/18 06:24:55 AM
#138011   At the current burn rate NNVC will be JG36 02/23/18 02:46:38 AM
#138010   No more gene? Say it isn’t so. noretreat 02/22/18 11:20:25 PM
#138009   "Fairly" could be good enough, was what I arvitar 02/22/18 09:10:16 PM
#138008   It was the "fairly" part of "fairly reproducible" loanranger 02/22/18 06:24:05 PM
#138007   These statements used by NNVC and others - arvitar 02/22/18 05:05:31 PM
#138006   Or they could all of the sudden be Its_lose_not_loose 02/22/18 04:49:36 PM
#138005   I’m afraid all indications are that you are NewMoney 02/22/18 04:46:58 PM
#138004   "in a fairly reproducible manner" loanranger 02/22/18 04:46:23 PM
#138003   Our progress towards IND stage is now constrained JG36 02/22/18 04:42:03 PM
#138002   "On January 27, 2018, the Company’s Chief Executive loanranger 02/22/18 04:39:24 PM
#138001   The scaling bottleneck (from the latest quarterly report): JG36 02/22/18 04:37:45 PM
#138000   I haven't heard of an instance when NNVC JG36 02/22/18 04:21:17 PM
#137999   It's too bad the company isn't more transparent. Its_lose_not_loose 02/22/18 02:19:53 PM
#137998   Diwan + Theracour own more NNVC stock than arvitar 02/22/18 02:17:17 PM
#137997   Dr Seymour knowing when to step down...I'm pretty Its_lose_not_loose 02/22/18 02:08:33 PM
#137995   I'm not surprised that no banks will help NewMoney 02/22/18 10:56:55 AM
#137994   Diwan does talk about failed funding around 0:46:00 arvitar 02/22/18 10:26:50 AM
#137993   Maybe I'll give it a listen the next Its_lose_not_loose 02/22/18 10:12:48 AM
PostSubject